Title : Combined therapy with weekly irinotecan, infusional 5-fluorouracil and the selective COX-2 inhibitor rofecoxib is a safe and effective second-line treatment in metastatic colorectal cancer.

Pub. Date : 2005 Oct

PMID : 16249351






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Combined therapy with weekly irinotecan, infusional 5-fluorouracil and the selective COX-2 inhibitor rofecoxib is a safe and effective second-line treatment in metastatic colorectal cancer. rofecoxib mitochondrially encoded cytochrome c oxidase II Homo sapiens